CD40 ligation on human cord blood CD34+ hematopoietic progenitors induces their proliferation and differentiation into functional dendritic cells

Journal of Experimental Medicine

Volumn 185, Issue 2, 1997, Pages 341-349

  Flores Romo, Leopoldo ^a   Björck, Pia ^a   Duvert, Valérie ^a   Van Kooten, Cees ^a   Saeland, Sem ^a   Banchereau, Jacques ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; DENDRITIC CELL; GROWTH REGULATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; IMMUNOREGULATION; LYMPHOCYTE DIFFERENTIATION; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL;

ANIMALS; ANTIGENS, CD34; ANTIGENS, CD40; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; CELL LINEAGE; DENDRITIC CELLS; FETAL BLOOD; HEMATOPOIETIC STEM CELLS; HUMANS; MICE;

EID: 1842335746     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.2.341     Document Type: Article

References (54)

1. Caux, C., C. Dezutter-Dambuyant, D. Schmitt, and J. Banchereau. 1992. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature (Lond.). 360: 258-261.
2. Galy, A., M. Travis, D. Cen, and B. Chen. 1995. Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity. 3:459-473.
3. + hematopoietic cells. Exp. Hematol. 20:24-33.
4. van Kooten, C., and J. Banchereau. 1996. CD40-CD40 ligand, a multifunctional receptor-ligand pair. Adv. Immunol. 61:1-77.
5. Banchereau, J., F. Bazan, D. Blanchard, F. Brière, J.P. Galizzi, C. van Kooten, Y.J. Liu, F. Rousset, and S. Saeland. 1994. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12:881-922.
6. Hollenbaugh, D., H.D. Ochs, R.J. Noelle, J.A. Ledbetter, and A. Aruffo. 1994. The role of CD40 and its ligand in the regulation of the immune response. Immunol. Rev. 138:23-37.
7. Noelle, R.J. 1996. CD40 and its ligand in host defense. Immunity. 4:415-119.
8. Liu, Y.J., D.E. Joshua, G.T. Williams, C.A. Smith, J. Gordon, and I.C.M. MacLennan. 1989. Mechanisms of antigen-driven selection in germinal centers. Nature (Lond.). 342: 929-931.
9. Jabara, H.H., S.M. Fu, R.S. Geha, and D. Vercelli. 1990. CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells. J. Exp. Med. 172:1861-1864.
10. Arpin, C., J. Déchanet, C. van Kooten, P. Merville, G. Grouard, F. Brière, J. Banchereau, and Y.-J. Liu. 1995. Generation of memory B cells and plasma cells in vitro. Science (Wash. DC). 268:720-722.
11. Banchereau, J., P. de Paoli, A. Vallé, E. Garcia, and F. Rousset. 1991. Long term human B cell lines dependent on interleukin 4 and antibody to CD40. Science (Wash. DC). 251:70-72.
12. Rousset, F., E. Garcia, and J. Banchereau. 1991. Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J. Exp. Med. 173:705-710.
13. Alderson, M.R., R.J. Armitage, T.W. Tough, L. Strockbine, W.C. Fanslow, and M.K. Spriggs. 1993. CD40 expression by human monocytes: Regulation by cytokines and activation of monocytes by the ligand for CD40. J. Exp. Med. 178:669-674.
14. Caux, C., C. Massacrier, B. Vanbervliet, B. Dubois, C. van Kooten, I. Durand, and J. Banchereau. 1994. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180:1263-1272.
15. Karmann, K., C.C.W. Hughes, J. Schechner, W.C. Fanslow, and J.S. Pober. 1995. CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Prof. Natl. Acad. Sci. USA. 92:4342-4346.
16. Hollenbaugh, D., N. Mischel-Petty, C. Edwards, J.C. Simon, R.W. Denfeld, P.A. Kiener, and A. Aruffo. 1995. Expression of functional CD40 by vascular endothelial cells. J. Exp. Med. 182:33-40.
17. Yellin, M.J., S. Winikoff, S.M. Fortune, D. Baum, M.K. Crow, S. Lederman, and L. Chess. 1995. Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) up-regulation and IL-6 production and proliferation. J. Leukocyte Biol. 58:209-216.
18. Galy, A.H.M., and H. Spits. 1992. CD40 is functionally expressed on human thymic epithelial cells. J. Immunol. 149: 775-782.
19. Saeland, S., V. Duvert, I. Moreau, and J. Banchereau. 1993. Human B cell precursors proliferate and express CD23 after CD40 ligation. J. Exp. Med. 178:113-120.
20. Fuleihan, R., N. Ramesh, R. Loh, H. Jabara, F.S. Rosen, T. Chatila, S.-M. Fu, I. Stamenkovic, and R.S. Geha. 1993. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc. Natl. Acad. Sci. USA. 90:2170-2173.
21. DiSanto, J.P., J.Y. Bonnefoy, J.F. Gauchat, A. Fischer, and G. de Saint Basile. 1993. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature (Lond.). 361: 541-543.
22. Aruffo, A., M. Farrington, D. Hollenbaugh, X. Li, A. Milatovich, S. Nonoyama, J. Bajorath, L.S. Grosmaire, R. Stenkamp, M. Neubauer et al. 1993. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell. 72:291-300.
23. Allen, R.C., R.J. Armitage, M.E. Conley, H. Rosenblatt, N.A. Jenkins, N.G. Copeland, M.A. Bedell, S. Edelhoff, C.M. Disteche, D.K. Simoneaux et al. 1993. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science (Wash. DC). 259:990-993.
24. Korthäuer, U., D. Graf, H.W. Mages, F. Brière, M. Padayachee, S. Malcolm, A.G. Ugazio, L.D. Notarangelo, R.J. Levinsky, and R.A. Kroczek. 1993. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature (Lond.). 361:539-541.
25. Notarangelo, L.D., M. Duse, and A.G. Ugazio. 1992. Immunodeficiency with hyper-IgM (HIM). Immunodef. Rev. 3: 101-122.
26. Burkly, L., C. Hession, L. Ogata, C. Reilly, L.A. Marconi, D. Olson, R. Tizard, R. Cate, and D. Lo. 1995. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature (Lond.). 373:531-536.
27. Szakal, A.K. 1989. Microanatomy of lymphoid tissue during humoral immune responses : structure function relationships. Annu. Rev. Immunol. 7:91-109.
28. Steinman, R.M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271-296.
29. Santiago-Schwarz, F., E. Belilos, B. Diamond, and S.E. Carsons. 1992. TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages. J. Leukocyte Biol. 52:274-281.
30. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179:1109-1118.
31. Romani, N., S. Gruner, D. Brang, E. Kämpgen, A. Lenz, B. Trockenbacher, G. Konwalinka, P.O. Fritsch, R.M. Steinman, and G. Schuler. 1994. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180:83-93.
32. Austyn, J.M., J.W. Kupiec-Weglinski, D.F. Hankins, and P.J. Morris. 1988. Migration patterns of dendritic cells in the mouse. Homing to T cell-dependent areas of spleen, and binding within marginal zone. J. Exp. Med. 167:646-651.
33. Liu, L.M., and G.G. MacPherson. 1993. Antigen acquisition by dendritic cells: intestinal dendritic cells acquire antigen administered orally and can prime naive T cells in vivo. J. Exp. Med. 177:1299-1307.
34. Zhou, L.-J., and T.F. Tedder. 1996. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc. Natl. Acad. Sci. USA. 93:2588-2592.
35. IL3 receptor-deficient mice are normal. Immunity. 2:211-222.
36. Dranoff, G., A.D. Crawford, M. Sadelain, B. Ream, A. Rashid, R.T. Bronson, G.R. Dickersin, C.J. Bachurski, E.L. Mark, J.A. Whitsett, and R.C. Mulligan. 1994. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science (Wash. DC). 264:713-716.
37. Facchetti, F., C. Appiani, L. Salvi, J. Levy, and L.D. Notarangelo. 1995. Immunohistologic analysis of ineffective CD40-CD40 ligand interaction in lymphoid tissues from patients with X-linked immunodeficiency with hyper-IgM. Abortive germinal center cell reaction and severe depletion of follicular dendritic cells. J. Immunol. 154:6624-6633.
38. Caux, C., B. Vanbervliet, C. Massacrier, B. Dubois, C. Dezutter-Dambuyant, D. Schmitt, and J. Banchereau. 1995. Characterization of human CD344+ derived dendritic/Langerhans cells (D-Lc). In Dendritic Cells in Fundamental and Clinical Immunology. J. Banchereau and D. Schmitt, editos. Plenum Press, London. 1-5.
39. Knight, S.C., and A.J. Stagg. 1993. Antigen-presenting cell types. Curr. Opin. Immunol. 5:374-382.
40. O'Doherty, U., M. Peng, S. Gezelter, W.J. Swiggard, M. Betjes, N. Bhardwaj, and R.M. Steinman. 1994. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology. 82: 487-493.
41. Weissman, D., Y. Li, J. Ananworanich, L.-J. Zhou, J. Adelsberger, T.F. Tedder, M. Baseler, and A.S. Fauci. 1995. Three populations of cells with dendritic morphology exist in peripheral blood, only one of which is infectable with human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA. 92:826-830.
42. Grewal, I.S., J. Xu, and R.A. Flavell. 1995. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature (Lond.). 378:617-620.
43. Renshaw, B.R., W.C. Fanslow III, R.J. Armitage, K.A. Campbell, D. Liggitt, B. Wright, B.L. Davison, and C.R. Maliszewski. 1994. Humoral immune responses in CD40 ligand-deficient mice. J. Exp. Med. 180:1889-1900.
44. Xu, J., T.M. Foy, J.D. Laman, E.A. Elliott, J.J. Dunn, T.J. Waldschmidt, J. Elsemore, R.J. Noelle, and R.A. Flavell. 1994. Mice deficient for the CD40 ligand. Immunity. 1:423-431.
45. Kamanaka, M., P. Yu, T. Yasui, K. Yosha, T. Kawabe, T. Horii, T. Kishimoto, and H. Kikutani. 1996. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity. 4:275-281.
46. Campbell, K.A., P.J. Ovendale, M.K. Kennedy, W.C. Fanslow, S.G. Reed, and C.R. Maliszewski. 1996. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity. 4:283-289.
47. Soong, L., J.-C. Xu, I.S. Grewal, P. Kima, J. Sun, B.J.J. Longley, N.H. Ruddle, D. McMahon-Pratt, and R.A. Flavell. 1996. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leschmania amazonensis infection. Immunity. 4:263-273.
48. Janossy, G., N. Tidman, E.S. Papageorgiou, P.C. Kung, and G. Goldstein. 1981. Distnbution of T lymphocyte subsets in the human bone marrow and thymus: an analysis with monoclonal antibodies. J. Immunol. 126:1608-1613.
49. Fauci, A. 1975. Human bone marrow lymphocytes. I. Distribution of lymphocyte subpopulations in the bone marrow of normal individuals. J. Clin. Invest. 56:98-110.
50. Shahidi, N.T., and W.B. Ershler. 1989. Bone marrow microenvironment: clinical observations. In Handbook of the Hemopoietic Microenvironment. M. Tavassoli, editor. Humana Press, Clifton, NJ. 433-444.
51. Garland, J.M. 1990. Lymphocytes, lymphokines, and hematopoiesis. In Colony Stimulating Factors, Molecular and Cellular Biology. T.M. Dexter, J.M. Garland and N.G. Testa, editors Marcel Dekker. New York. 297-328.
52. Shin, S.S., K. Sheibani, J. Kezinan, A. Nademanee, S.J. Forman, S.K. Lee, and C.D. Winberg. 1992. Immunoarchitecture of normal human bone marrow: a study of frozen and fixed tissue sections. Hum. Pathol. 23:686-694
53. + T cell clone recognizing autologous hematopoietic progenitor cells from a patient with immune-mediated aplastic anemia. Exp. Hematol. 23:433-438.
54. Gauchat, J.F., S. Henchoz, G. Mazzei, J.P. Aubry, T. Brunner, H. Blasey, P. Life, D. Talabot, L. Flores-Romo, J. Thompson et al. 1993. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature (Lond.). 365:340-343.